Search results
Results from the WOW.Com Content Network
G62.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM G62.0 became effective on October 1, 2024. This is the American ICD-10-CM version of G62.0 - other international versions of ICD-10 G62.0 may differ.
Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling complication of many chemotherapies. ... (Polyneuropathy due to drugs) or ICD-10-CM G62.0 (Drug-induced polyneuropathy). A new NDC code for gabapentin, pregabalin, or duloxetine was used to identify new pharmacy dispensings of these drugs since initiation of chemotherapy.
Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, pain, and tingling or a “pins and needles” feeling — is a common side effect of chemotherapy treatment. Sometimes described as “chemo feet” and “chemo hands,” chemotherapy-induced peripheral neuropathy (CIPN) affects the body in what is called a sock-and ...
T45.1X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Adverse effect of antineoplastic and immunosup drugs, init. The 2025 edition of ICD-10-CM T45.1X5A became effective on October 1, 2024.
Chemotherapy-induced neuropathy is a serious clinical problem caused by a substantial number of cytotoxic drugs, including taxanes, platinums, vinca alkaloids, epothilones, eribulin, and bortezomib; these drugs cause different pathologic insults to neurons.
An overview of neurologic complications with platinum and non-platinum chemotherapy drugs, and recommendations for dose modification for platinum and non-platinum chemotherapeutic drugs when neuropathy develops during therapy are provided elsewhere.
This patient page describes the risks, symptoms, complications, and recommended treatment options for chemotherapy-induced peripheral neuropathy.
Chemotherapy-induced neuropathy is a serious clin-ical problem caused by a substantial number of cy-totoxic drugs, including taxanes, platinums, vinca alkaloids, epothilones, eribulin, and bortezomib; these drugs cause different pathologic insults to neurons.
Chemotherapy-induced peripheral neuropathy (CIPN) is a progressive, enduring, and often irre-versible adverse effect of many antineoplastic agents, among which sensory abnormities are common and the most suffering issues.
Some of the most common causes of peripheral neuropathy are medicines used to treat cancer. When this happens, it is called chemotherapy-induced peripheral neuropathy (CIPN). The risk of CIPN depends on the type of chemotherapy and dose given, and increases with each cycle of chemotherapy.